Plus Therapeutics Inc (PSTV)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-09-17 | 2024-09-13 | B Purchase | Non-Executive Director |
4,000
+35.8%
1.50USD 5,996 |
4,000 +35.8% | 1.50 | USD 5,996 | |
| 2024-09-16 | 2024-09-12 | B Purchase | Non-Executive Director |
6,285
+128.2%
1.35USD 8,512 |
6,285 +128.2% | 1.35 | USD 8,512 | |
| 2024-09-13 | 2024-09-11 | B Purchase | Non-Executive Director |
5,000
+23.3%
1.34USD 6,681 |
5,000 +23.3% | 1.34 | USD 6,681 | |
| 2024-09-13 | 2024-09-11 | B Purchase | Non-Executive Director |
12,500
+34.3%
1.35USD 16,875 |
12,500 +34.3% | 1.35 | USD 16,875 | |
| 2024-09-11 | 2024-09-10 | B Purchase |
Sims Andrew John Hugh MacIntyre Chief Financial Officer Officer |
4,098
+71.7%
1.27USD 5,204 |
4,098 +71.7% | 1.27 | USD 5,204 | |
| 2024-09-11 | 2024-09-10 | B Purchase |
Chief Executive Officer Executive Director |
8,000
+64.4%
1.23USD 9,839 |
8,000 +64.4% | 1.23 | USD 9,839 | |
| 2024-05-10 | 2024-05-08 | B Purchase | Non-Executive Director |
4,167
+16.6%
2.04USD 8,501 |
4,167 +16.6% | 2.04 | USD 8,501 | |
| 2024-05-10 | 2024-05-08 | B Purchase | Non-Executive Director |
4,167
+16.6%
2.04USD 8,501 |
4,167 +16.6% | 2.04 | USD 8,501 | |
| 2024-05-10 | 2024-05-08 | B Purchase | Non-Executive Director |
9,804
+83.8%
2.04USD 20,000 |
9,804 +83.8% | 2.04 | USD 20,000 | |
| 2024-05-10 | 2024-05-08 | B Purchase |
Chief Executive Officer Executive Director |
12,255
+7208.8%
2.04USD 25,000 |
12,255 +7208.8% | 2.04 | USD 25,000 | |
| 2024-05-10 | 2024-05-08 | B Purchase | Non-Executive Director |
12,255
+50.7%
2.04USD 25,000 |
12,255 +50.7% | 2.04 | USD 25,000 | |
| 2024-05-10 | 2024-05-08 | B Purchase |
Sims Andrew John Hugh MacIntyre Chief Financial Officer Officer |
4,902
+601.5%
2.04USD 10,000 |
4,902 +601.5% | 2.04 | USD 10,000 | |
| 2024-05-10 | 2024-05-08 | B Purchase | Non-Executive Director |
4,902
+490200.0%
2.04USD 10,000 |
4,902 +490200.0% | 2.04 | USD 10,000 | |
| 2023-12-15 | 2023-11-20 | S Sale |
Chief Executive Officer Executive Director |
2,068
-92.4%
1.96USD 4,053 |
2,068 -92.4% | 1.96 | USD 4,053 | |
| 2023-11-17 | 2023-11-16 | B Purchase | Non-Executive Director |
1,000
+4.1%
1.95USD 1,950 |
1,000 +4.1% | 1.95 | USD 1,950 | |
| 2023-11-17 | 2023-11-15 | B Purchase | Non-Executive Director |
1,000
+4.3%
1.77USD 1,770 |
1,000 +4.3% | 1.77 | USD 1,770 | |
| 2023-11-15 | 2023-11-13 | B Purchase | Non-Executive Director |
4,000
+20.9%
1.43USD 5,720 |
4,000 +20.9% | 1.43 | USD 5,720 | |
| 2023-11-15 | 2023-11-10 | B Purchase | Non-Executive Director |
2,000
+11.7%
1.45USD 2,900 |
2,000 +11.7% | 1.45 | USD 2,900 | |
| 2023-11-13 | 2023-11-09 | B Purchase | Non-Executive Director |
4,199
+32.4%
1.59USD 6,676 |
4,199 +32.4% | 1.59 | USD 6,676 | |
| 2023-11-13 | 2023-11-08 | B Purchase | Non-Executive Director |
5,000
+62.8%
1.65USD 8,250 |
5,000 +62.8% | 1.65 | USD 8,250 |